Literature DB >> 10643626

Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.

R Wiest1, R J Groszmann.   

Abstract

In recent years it has become well established that nitric oxide (NO) plays a crucial role in the hemodynamic abnormalities that develop in chronic portal hypertension. The purpose of this review is to summarize the available data and current concepts regarding the involvement of NO in the pathophysiologic changes in the micro-circulation of the liver and the splanchnic and systemic circulation that associate portal hypertension.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10643626     DOI： 10.1055/s-2007-1007129

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


  22 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Hepatorenal syndrome.

Authors:  Charles K F Ng; Michael H M Chan; Morris H L Tai; Christopher W K Lam
Journal:  Clin Biochem Rev       Date:  2007-02

Review 3.  [Hepatorenal syndrome].

Authors:  G Huschak; U X Kaisers; S Laudi
Journal:  Anaesthesist       Date:  2013-07       Impact factor: 1.041

4.  Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension.

Authors:  Lukas Moleda; Lars Jurzik; Matthias Froh; Erwin Gäbele; Claus Hellerbrand; Rainer H Straub; Jürgen Schölmerich; Reiner Wiest
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

5.  Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.

Authors:  Soichiro Kiyono; Hitoshi Maruyama; Takayuki Kondo; Tadashi Sekimoto; Taro Shimada; Masanori Takahashi; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2016-01-18       Impact factor: 7.527

6.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

7.  Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.

Authors:  Yin-Ying Lu; Chun-Ping Wang; Lin Zhou; Yan Chen; Shu-Hui Su; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.

Authors:  M Ghasemi; H Sadeghipour; H Shafaroodi; B G Nezami; T Gholipour; A R Hajrasouliha; S Tavakoli; M Nobakht; K P Moore; A R Mani; A R Dehpour
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

9.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

10.  Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.

Authors:  K S Park; Y Li; Y Zhang; A L Gerbes; H Liu; M G Swain; S S Lee
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.